Literature DB >> 33161473

Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-γ-dependent regulation of ADPN/FGF9 pathway.

Xiao-Qing Wang1,2, Ya-Hui Tang2, Gui-Rong Zeng2, Li-Feng Wu2, Ying-Jun Zhou1, Ze-Neng Cheng3, De-Jian Jiang4.   

Abstract

RATIONALE: The pathway of adiponectin (ADPN)/fibroblast growth factor 9 (FGF9) was recently thought as a key role in the development of depression. ADPN is crucially regulated by peroxisome proliferator-activated receptor-gamma (PPAR-γ). Natural material carnosic acid (CA) has been applied for therapeutics of mental disorders.
OBJECTIVES: To evaluate the antidepressive effect of CA in stress-treated mice and define whether its effects is involved in the regulation of ADPN/FGF9 pathway.
METHODS: In vivo study, the levels of ADPN and FGF9 in both serum and hippocampus tissues, the expressions of ADPN receptor 2 (AdipoR2) in hippocampus and PPAR-γ in abdominal adipose, as well as the pathological changes of hippocampus were determined in 28-day period of chronic unpredictable mild stress (CUMS)-induced depression model of male ICR (Institute of Cancer Research) mice or adipo-/- mice. In vitro study, the level of ADPN and the mRNA expressions of both ADPN and PPAR-γ were determined in mouse 3T3-L1 preadipocytes.
RESULTS: In vivo study, treatment with CA (50 or 100 mg/kg per day) for 21 days markedly suppressed depressive-like behaviors, the elevating levels of FGF9 and decreasing levels of ADPN in both serum and hippocampus tissues, the downregulating protein and mRNA expressions of AdipoR2 in hippocampus and PPAR-γ in abdominal adipose, as well as the pathological injury of hippocampus induced by CUMS in male ICR mice. The antidepressive effects of CA were markedly attenuated in male CUMS-treated adipo-/- mice. In vitro study, incubation with CA (3-30 μmol/L) for 24 h could concentration-dependently upregulate the mRNA expressions of both PPAR-γ and ADPN as well as increase the level of ADPN. The experiments using PPAR-γ-specific inhibitor GW9662 and transient transfection with mutated PPAR-γ-binding site promotor constructs showed that the activation of PPAR-γ mediated CA-induced ADPN expression in adipocytes.
CONCLUSIONS: CA could significantly improve stress-induced depressive disorder, which may be related to regulating the dysfunction of ADPN-FGF9 pathway via activating PPAR-γ in adipocytes.

Entities:  

Keywords:  Adiponectin; Depression; Fibroblast growth factor 9; Peroxisome proliferator-activated receptor-gamma

Year:  2020        PMID: 33161473     DOI: 10.1007/s00213-020-05699-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

1.  Fibroblast growth factor 9 is a novel modulator of negative affect.

Authors:  Elyse L Aurbach; Edny Gula Inui; Cortney A Turner; Megan H Hagenauer; Katherine E Prater; Jun Z Li; Devin Absher; Najmul Shah; Peter Blandino; William E Bunney; Richard M Myers; Jack D Barchas; Alan F Schatzberg; Stanley J Watson; Huda Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

2.  Cang-ai volatile oil improves depressive-like behaviors and regulates DA and 5-HT metabolism in the brains of CUMS-induced rats.

Authors:  Bojun Chen; Jijun Li; Yuhuan Xie; Xi Ming; Gang Li; Jinjin Wang; Meng Li; Xiaohong Li; Lei Xiong
Journal:  J Ethnopharmacol       Date:  2019-07-16       Impact factor: 4.360

3.  Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study.

Authors:  Giovanni Cizza; Vi T Nguyen; Farideh Eskandari; Zhigang Duan; Elizabeth C Wright; James C Reynolds; Rexford S Ahima; Marc R Blackman
Journal:  J Clin Psychiatry       Date:  2010-05-18       Impact factor: 4.384

4.  Low glial numbers in the amygdala in major depressive disorder.

Authors:  Michael P Bowley; Wayne C Drevets; Dost Ongür; Joseph L Price
Journal:  Biol Psychiatry       Date:  2002-09-01       Impact factor: 13.382

5.  Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.

Authors:  R Bernard; I A Kerman; R C Thompson; E G Jones; W E Bunney; J D Barchas; A F Schatzberg; R M Myers; H Akil; S J Watson
Journal:  Mol Psychiatry       Date:  2010-04-13       Impact factor: 15.992

6.  Neuroprotective effects of carnosic Acid in an experimental model of Alzheimer's disease in rats.

Authors:  Nahid Azad; Homa Rasoolijazi; Mohammad Taghi Joghataie; Sara Soleimani
Journal:  Cell J       Date:  2011-04-21       Impact factor: 2.479

Review 7.  The Dietary Components Carnosic Acid and Carnosol as Neuroprotective Agents: a Mechanistic View.

Authors:  Marcos Roberto de Oliveira
Journal:  Mol Neurobiol       Date:  2015-11-09       Impact factor: 5.590

8.  Seasonal affective disorder and seasonal changes in weight and sleep duration are inversely associated with plasma adiponectin levels.

Authors:  Faisal Akram; Claudia Gragnoli; Uttam K Raheja; Soren Snitker; Christopher A Lowry; Kelly A Stearns-Yoder; Andrew J Hoisington; Lisa A Brenner; Erika Saunders; John W Stiller; Kathleen A Ryan; Kelly J Rohan; Braxton D Mitchell; Teodor T Postolache
Journal:  J Psychiatr Res       Date:  2020-01-02       Impact factor: 4.791

9.  Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.

Authors:  Małgorzata Bednarska-Makaruk; Ałła Graban; Anna Wiśniewska; Wanda Łojkowska; Anna Bochyńska; Magdalena Gugała-Iwaniuk; Ksenia Sławińska; Agnieszka Ługowska; Danuta Ryglewicz; Hanna Wehr
Journal:  Biogerontology       Date:  2017-04-18       Impact factor: 4.277

Review 10.  Role of Adiponectin in Central Nervous System Disorders.

Authors:  Jenna Bloemer; Priyanka D Pinky; Manoj Govindarajulu; Hao Hong; Robert Judd; Rajesh H Amin; Timothy Moore; Muralikrishnan Dhanasekaran; Miranda N Reed; Vishnu Suppiramaniam
Journal:  Neural Plast       Date:  2018-07-29       Impact factor: 3.599

View more
  3 in total

Review 1.  Novel Pharmacological Approaches to the Treatment of Depression.

Authors:  Elias Elias; Ariel Y Zhang; Melissa T Manners
Journal:  Life (Basel)       Date:  2022-01-28

2.  Gut Microbiota-Related Inflammation Factors as a Potential Biomarker for Diagnosing Major Depressive Disorder.

Authors:  Shunjie Bai; Huili Bai; Detao Li; Qi Zhong; Jing Xie; Jian-Jun Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-03-15       Impact factor: 5.293

3.  Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer's Disease.

Authors:  Nishat Malik; Sanila Amber; Saadia Zahid
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.